Zhang Xiaoyan Michelle 4
4 · Ikena Oncology, Inc. · Filed Dec 14, 2021
Insider Transaction Report
Form 4
Zhang Xiaoyan Michelle
Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-12-10$14.76/sh−1,000$14,760→ 44,475 total - Exercise/Conversion
Common Stock
2021-12-10$2.15/sh+1,000$2,146→ 45,475 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-10−1,000→ 25,473 totalExercise: $2.15Exp: 2028-12-17→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option vested and became exercisable on December 14, 2018, with the remainder vesting in 36 substantially equal monthly installments thereafter.